Impact of albuminuria on relation of left ventricular hypertrophy to markers of inflammation in the overall study population
| LVH | Normal LV mass | Adjusted P | |
|---|---|---|---|
| Fibrinogen (mg/dl) | 394 ± 86 | 383 ± 81 | 0.05 |
| hsCRP (mg/l) | 9.1 ± 11.8 | 7.5 ± 11.2 | NS (0.5) |
Data are adjusted means ± SD; variables tested after log-transformation. P adjusted for albuminuria, age, sex, smoking status, BMI, sBP, history of hypertension, HbA1c, plasma creatinine and lipids levels, use of major antihypertensive drug classes and lipid-lowering agents, and wall motion abnormalities.